;PMID: 6585591
;source_file_834.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..43] = [t:0..43]
;1)sentence:[e:49..135] = [t:49..135]
;2)section:[e:139..165] = [t:139..164]
;3)sentence:[e:169..331] = [t:169..331]
;4)sentence:[e:332..585] = [t:332..585]
;5)sentence:[e:586..741] = [t:586..741]
;6)sentence:[e:742..848] = [t:742..848]
;7)sentence:[e:849..932] = [t:849..932]
;8)sentence:[e:933..1149] = [t:933..1149]
;9)sentence:[e:1150..1243] = [t:1150..1243]
;10)sentence:[e:1244..1343] = [t:1244..1343]
;11)section:[e:1347..1391] = [t:1347..1390]
;Sentence Matching Errors
;ERROR_Section end mismatch[e:139..165][t:139..164]
;ERROR_Section end mismatch[e:1347..1391][t:1347..1390]
;Token/POS Errors
;ERROR_Token in entity file but not tree[164..165] .
;ERROR_Token in entity file but not tree[1390..1391] ]

;section 0 Span:0..43
;J Natl Cancer Inst. 1984 May;72(5):1167-71.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..6] Natl) (NNP:[7..13] Cancer)
        (NNP:[14..18] Inst) (.:[18..19] .) (CD:[20..24] 1984)
        (CC:[25..32] May;72-LRB-) (CD:[32..33] 5) (-RRB-:[33..34] -RRB-)
        (CD:[34..39] :1167) (::[39..40] -) (CD:[40..42] 71) (.:[42..43] .)))

;sentence 1 Span:49..135
;Effects of riboflavin on the dimethylnitrosamine demethylase system in the
;rat  liver.
;[60..70]:substance:"riboflavin"
;[78..109]:cyp450:"dimethylnitrosamine demethylase"
(SENT
  (NP-HLN
    (NP
      (NP (NNS:[49..56] Effects))
      (PP (IN:[57..59] of)
        (NP (NN:[60..70] riboflavin))))
    (PP (IN:[71..73] on)
      (NP (DT:[74..77] the)
        (NML (NN:[78..97] dimethylnitrosamine) (NN:[98..109] demethylase))
        (NN:[110..116] system)))
    (PP-LOC (IN:[117..119] in)
      (NP (DT:[120..123] the) (NN:[124..127] rat) (NN:[129..134] liver)))
    (.:[134..135] .)))

;section 2 Span:139..164
;Ruchirawat M, Saengchan S
(SEC
  (FRAG (NNP:[139..149] Ruchirawat) (NNP:[150..151] M) (,:[151..152] ,)
        (NNP:[153..162] Saengchan) (NNP:[163..164] S)))

(ORPH .)

;sentence 3 Span:169..331
;The effects of riboflavin on the dimethylnitrosamine [(DMN) CAS: 62-75-9; 
;N-nitrosodimethylamine] demethylase system in inbred F344 rat liver were 
;investigated.
;[184..194]:substance:"riboflavin"
;[202..279]:cyp450:"dimethylnitrosamine [(DMN) CAS: 62-75-9; 
;N-nitrosodimethylamine] demethylase"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[169..172] The) (NNS:[173..180] effects))
      (PP (IN:[181..183] of)
        (NP (NN:[184..194] riboflavin)))
      (PP (IN:[195..197] on)
        (NP (DT:[198..201] the)
           (NN:[202..221] dimethylnitrosamine)
          (PRN (-LRB-:[222..223] -LSB-)
            (FRAG (-LRB-:[223..224] -LRB-) (NN:[224..227] DMN)
                  (-RRB-:[227..228] -RRB-) (NN:[229..232] CAS) (::[232..233] :)
                  (CD:[234..236] 62) (HYPH:[236..237] -) (CD:[237..239] 75)
                  (HYPH:[239..240] -) (CD:[240..241] 9) (::[241..242] ;)
                  (NN:[244..266] N-nitrosodimethylamine))
            (-RRB-:[266..267] -RSB-))
          (NN:[268..279] demethylase)
          (NN:[280..286] system)))
      (PP (IN:[287..289] in)
        (NP (JJ:[290..296] inbred) (NN:[297..301] F344) (NN:[302..305] rat)
            (NNS:[306..311] liver))))
    (VP (VBD:[312..316] were)
      (NP (VBN:[318..330] investigated)
        (NP-1 (-NONE-:[330..330] *))))
    (.:[330..331] .)))
;ERROR_Orphan Text from Tree File[164..169] .

;sentence 4 Span:332..585
;Dietary riboflavin deficiency markedly stimulated the activity of  DMN
;demethylase I operating at a low substrate concentration (4 mM), but it 
;caused no change in the activity of DMN demethylase II operating at a high 
;substrate concentration (200 mM).
;[340..350]:substance:"riboflavin"
;[399..416]:cyp450:"DMN demethylase I"
;[436..445]:substance:"substrate"
;[461..462]:quantitative-value:"4"
;[463..465]:quantitative-units:"mM"
;[512..530]:cyp450:"DMN demethylase II"
;[552..561]:substance:"substrate"
;[577..580]:quantitative-value:"200"
;[581..583]:quantitative-units:"mM"
(SENT
  (S
    (S
      (NP-SBJ (JJ:[332..339] Dietary) (NN:[340..350] riboflavin)
              (NN:[351..361] deficiency))
      (VP
        (ADVP (RB:[362..370] markedly))
        (VBD:[371..381] stimulated)
        (NP
          (NP (DT:[382..385] the) (NN:[386..394] activity))
          (PP (IN:[395..397] of)
            (NP
              (NP (NN:[399..402] DMN) (NN:[403..414] demethylase)
                  (CD:[415..416] I))
              (VP (VBG:[417..426] operating)
                (PP (IN:[427..429] at)
                  (NP (DT:[430..431] a) (JJ:[432..435] low)
                      (NN:[436..445] substrate) (NN:[446..459] concentration)
                    (PRN (-LRB-:[460..461] -LRB-)
                      (NP (CD:[461..462] 4) (NN:[463..465] mM))
                      (-RRB-:[465..466] -RRB-))))))))))
    (,:[466..467] ,) (CC:[468..471] but)
    (S
      (NP-SBJ (PRP:[472..474] it))
      (VP (VBD:[476..482] caused)
        (NP
          (NP (DT:[483..485] no) (NN:[486..492] change))
          (PP (IN:[493..495] in)
            (NP
              (NP (DT:[496..499] the) (NN:[500..508] activity))
              (PP (IN:[509..511] of)
                (NP
                  (NP (NN:[512..515] DMN) (NN:[516..527] demethylase)
                      (CD:[528..530] II))
                  (VP (VBG:[531..540] operating)
                    (PP (IN:[541..543] at)
                      (NP (DT:[544..545] a) (JJ:[546..550] high)
                          (NN:[552..561] substrate)
                          (NN:[562..575] concentration)
                        (PRN (-LRB-:[576..577] -LRB-)
                          (NP (CD:[577..580] 200) (NN:[581..583] mM))
                          (-RRB-:[583..584] -RRB-))))))))))))
    (.:[584..585] .)))

;sentence 5 Span:586..741
;This effect could be reversed by short-term  supplementation of the vitamin
;by a series of three ip injections (0.5  mg/dose/day) to the deficient
;animals.
;[654..661]:substance:"vitamin"
;[698..701]:quantitative-value:"0.5"
;[703..714]:quantitative-units:"mg/dose/day"
(SENT
  (S
    (NP-SBJ-1 (DT:[586..590] This) (NN:[591..597] effect))
    (VP (MD:[598..603] could)
      (VP (VB:[604..606] be)
        (VP (VBN:[607..615] reversed)
          (NP-1 (-NONE-:[615..615] *))
          (PP (IN:[616..618] by)
            (NP-LGS
              (NP (JJ:[619..629] short-term) (NN:[631..646] supplementation))
              (PP (IN:[647..649] of)
                (NP (DT:[650..653] the) (NN:[654..661] vitamin)))
              (PP (IN:[662..664] by)
                (NP
                  (NP (DT:[665..666] a) (NN:[667..673] series))
                  (PP (IN:[674..676] of)
                    (NP
                      (NP
                        (NP (CD:[677..682] three) (NN:[683..685] ip)
                            (NNS:[686..696] injections))
                        (NP (-LRB-:[697..698] -LRB-)
                          (NP (CD:[698..701] 0.5) (NN:[703..705] mg))
                          (PP (SYM:[705..706] /)
                            (NP (NN:[706..710] dose)))
                          (PP (SYM:[710..711] /)
                            (NP (NN:[711..714] day)))
                          (-RRB-:[714..715] -RRB-)))
                      (PP (TO:[716..718] to)
                        (NP (DT:[719..722] the) (JJ:[723..732] deficient)
                            (NNS:[733..740] animals))))))))))))
    (.:[740..741] .)))

;sentence 6 Span:742..848
;This dosage regimen of riboflavin did not  change the activity of DMN
;demethylase I in the normal animals.
;[765..775]:substance:"riboflavin"
;[808..825]:cyp450:"DMN demethylase I"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[742..746] This) (NN:[747..753] dosage) (NN:[754..761] regimen))
      (PP (IN:[762..764] of)
        (NP (NN:[765..775] riboflavin))))
    (VP (VBD:[776..779] did) (RB:[780..783] not)
      (VP (VB:[785..791] change)
        (NP
          (NP (DT:[792..795] the) (NN:[796..804] activity))
          (PP (IN:[805..807] of)
            (NP (NN:[808..811] DMN) (NN:[812..823] demethylase)
                (CD:[824..825] I))))
        (PP (IN:[826..828] in)
          (NP (DT:[829..832] the) (JJ:[833..839] normal)
              (NNS:[840..847] animals)))))
    (.:[847..848] .)))

;sentence 7 Span:849..932
;The study in  vitro demonstrated that flavins were inhibitory to DMN
;demethylase I.
;[887..894]:substance:"flavins"
;[914..931]:cyp450:"DMN demethylase I"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[849..852] The) (NN:[853..858] study))
      (ADJP (FW:[859..861] in) (FW:[863..868] vitro)))
    (VP (VBD:[869..881] demonstrated)
      (SBAR (IN:[882..886] that)
        (S
          (NP-SBJ (NNS:[887..894] flavins))
          (VP (VBD:[895..899] were)
            (ADJP-PRD (JJ:[900..910] inhibitory)
              (PP (TO:[911..913] to)
                (NP (NN:[914..917] DMN) (NN:[918..929] demethylase)
                    (CD:[930..931] I))))))))
    (.:[931..932] .)))

;sentence 8 Span:933..1149
;The enzyme  activity in the microsomes of both control and deficient animals
;was inhibited  by preincubation with flavins, suggesting that the interaction
;between flavins  and the enzyme rendered the enzyme inactive.
;[937..943]:substance:"enzyme"
;[1047..1054]:substance:"flavins"
;[1096..1103]:substance:"flavins"
;[1113..1119]:substance:"enzyme"
;[1133..1139]:substance:"enzyme"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[933..936] The) (NN:[937..943] enzyme) (NN:[945..953] activity))
      (PP-LOC (IN:[954..956] in)
        (NP (DT:[957..960] the) (NNS:[961..971] microsomes)))
      (PP (IN:[972..974] of)
        (NP (CC:[975..979] both)
          (NP (JJ:[980..987] control)
            (NML-1 (-NONE-:[987..987] *P*)))
          (CC:[988..991] and)
          (NP (JJ:[992..1001] deficient)
            (NML-1 (NNS:[1002..1009] animals))))))
    (VP (VBD:[1010..1013] was)
      (VP (VBN:[1014..1023] inhibited)
        (NP-2 (-NONE-:[1023..1023] *))
        (PP (IN:[1025..1027] by)
          (NP-LGS
            (NP (NN:[1028..1041] preincubation))
            (PP (IN:[1042..1046] with)
              (NP (NNS:[1047..1054] flavins)))))
        (,:[1054..1055] ,)
        (S-ADV
          (NP-SBJ (-NONE-:[1055..1055] *))
          (VP (VBG:[1056..1066] suggesting)
            (SBAR (IN:[1067..1071] that)
              (S
                (NP-SBJ
                  (NP (DT:[1072..1075] the) (NN:[1076..1087] interaction))
                  (PP (IN:[1088..1095] between)
                    (NP
                      (NP (NNS:[1096..1103] flavins))
                      (CC:[1105..1108] and)
                      (NP (DT:[1109..1112] the) (NN:[1113..1119] enzyme)))))
                (VP (VBD:[1120..1128] rendered)
                  (S
                    (NP-SBJ (DT:[1129..1132] the) (NN:[1133..1139] enzyme))
                    (ADJP-PRD (JJ:[1140..1148] inactive))))))))))
    (.:[1148..1149] .)))

;sentence 9 Span:1150..1243
;Flavin adenine dinucleotide (FAD)  appeared to have a more pronounced effect
;than riboflavin.
;[1150..1177]:substance:"Flavin adenine dinucleotide"
;[1179..1182]:substance:"FAD"
;[1232..1242]:substance:"riboflavin"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[1150..1156] Flavin) (NN:[1157..1164] adenine)
          (NN:[1165..1177] dinucleotide))
      (NP (-LRB-:[1178..1179] -LRB-) (NN:[1179..1182] FAD)
          (-RRB-:[1182..1183] -RRB-)))
    (VP (VBD:[1185..1193] appeared)
      (S
        (NP-SBJ-1 (-NONE-:[1193..1193] *))
        (VP (TO:[1194..1196] to)
          (VP (VB:[1197..1201] have)
            (NP
              (NP (DT:[1202..1203] a)
                (ADJP (RBR:[1204..1208] more) (JJ:[1209..1219] pronounced))
                (NN:[1220..1226] effect))
              (PP (IN:[1227..1231] than)
                (NP (NN:[1232..1242] riboflavin))))))))
    (.:[1242..1243] .)))

;sentence 10 Span:1244..1343
;In agreement with the  earlier observation, DMN demethylase II was unaffected
;by FAD or riboflavin.
;[1288..1306]:cyp450:"DMN demethylase II"
;[1325..1328]:substance:"FAD"
;[1332..1342]:substance:"riboflavin"
(SENT
  (S
    (PP (DT:[1244..1246] In)
      (NP
        (NP (NN:[1247..1256] agreement))
        (PP (IN:[1257..1261] with)
          (NP (DT:[1262..1265] the) (JJR:[1267..1274] earlier)
              (NN:[1275..1286] observation)))))
    (,:[1286..1287] ,)
    (NP-SBJ (NN:[1288..1291] DMN) (NN:[1292..1303] demethylase)
            (CD:[1304..1306] II))
    (VP (VBD:[1307..1310] was)
      (ADJP-PRD (JJ:[1311..1321] unaffected)
        (PP (IN:[1322..1324] by)
          (NP (NN:[1325..1328] FAD) (CC:[1329..1331] or)
              (NN:[1332..1342] riboflavin)))))
    (.:[1342..1343] .)))

;section 11 Span:1347..1390
;PMID: 6585591 [PubMed - indexed for MEDLINE
(SEC
  (FRAG (NNP:[1347..1351] PMID) (::[1351..1352] :) (CD:[1353..1360] 6585591)
        (-LRB-:[1361..1362] -LSB-) (NNP:[1362..1368] PubMed) (::[1369..1370] -)
        (VBN:[1371..1378] indexed) (IN:[1379..1382] for)
        (NNP:[1383..1390] MEDLINE)))
;ERROR_Orphan Text from EOF Tree File[1390..EOF] ]

(ORPH -RSB-)
